L'Oréal

Arizona’s attorney general has filed suit against L’Oreal, accusing the company of hiding evidence that hair-straightening products can cause ovarian and uterine cancer. The lawsuit alleges L’Oreal sold products—used predominantly by women of African descent—without warning labels, violating consumer protection laws. Arizona seeks fines, damages and a court order banning sales without warnings. L’Oreal already faces more than 12,000 similar lawsuits consolidated in a multidistrict litigation in Chicago. » Mere på de.investing.com

Barclays sees L’Oreal as the main beneficiary of the selective beauty market, where brand strength and innovation determine winners. Positive H1 results from Puig indicate continued demand in the premium and luxury segments, with fragrances and make-up remaining dynamic and dermocosmetics gaining market share. According to Barclays, L’Oreal scores particularly in dermocosmetics and records around 7% growth in the US and Europe, along with strong APAC growth. Recent developments: an exclusive 50‑year beauty license with Gucci (first products in 2028) and an analyst upgrade due to good inflation management. » Mere på de.investing.com

L'Oréal increased sales in the second quarter by around 8% to €11.6 billion; adjusted for currency effects and portfolio changes, growth was 6.3%. The share rose about 4% in Paris and is up roughly 9% year-to-date. In the first half, the group generated revenues of €23.8 billion, an operating profit of €5.06 billion (+6.8%) and a net profit of just over €3.5 billion (+5%); analysts described the figures overall as strong to solid under the leadership of Nicolas Hieronimus. » Mere på finanzen.net